Skip to main content
Log in

Cisapride Use During Human Pregnancy (A Prospective, Controlled Multicenter Study)

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The objective of this prospective multicenterstudy was to determine whether cisapride is associatedwith increased risk of malformations, spontaneousabortions, or decreased birthweight when used during pregnancy. Cases were paired for age, smoking,and alcohol consumption with controls exposed tononteratogens, as well as with disease-paired controls.One hundred and twenty-nine pregnant women were exposed to cisapride during pregnancy, including 88during the period of fetal organogenesis. There were nodifferences in maternal history, birthweight,gestational age at delivery, and rates of livebirths,spontaneous or therapeutic abortions, fetal distress, andmajor or minor malformations among groups. It isconcluded that exposure to cisapride during pregnancy isnot associated with a major increased risk ofmalformations or spontaneous abortions or with decreasedbirthweight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Barone JA, Jessen LM, Colaizzi JI, Bierman RH: Cisapride: A gastrointestinal prokinetic drug. Ann Pharmacother 28:488–500, 1994

    Google Scholar 

  2. Bruton LL: Agents affecting gastrointestinal water flux and motility; Emesis and antiemetics; bile acids and pancreatic enzymes. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilman (eds). New York, McGraw-Hill, 1996, p 933

    Google Scholar 

  3. McCallum RW: Cisapride: A new class of prokinetic agent. Am J Gastroenterol 86:135–149, 1991

    Google Scholar 

  4. Bennett JR: How safe and acceptable is cisapride? Scand J Gastroenterol 24:59–61, 1989

    Google Scholar 

  5. Van Neuten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ, Schuurkes JAJ: Gastrointestinal motility stimulating properties of cisapride, a non-antidopaminergic non-cholinergic compound. In Gastrointestinal Motility: C Roman (ed). Hingham, MTP Press, 1984, pp 513–520

    Google Scholar 

  6. Schuurkes JAJ, Van Nueten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ: Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 234:775–783, 1985

    Google Scholar 

  7. Everson GT: Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 21:751–776, 1992

    Google Scholar 

  8. Simone C, Derewlany LO, Koren G: Drug transfer across the placenta. Considerations in treatment and research. Clin Perinatol 21:463–468, 1994

    Google Scholar 

  9. Pelligrini EM, Koren G: Motherisk I: A new model for counseling in reproductive toxicology. In Maternal-Fetal Toxicology: A Clinician's Guide. G Koren (ed). New York, Dekker, 1994, pp 707–725

    Google Scholar 

  10. Stevenson RE: Causes of human anomalies: An overview and historical perspective. In Human Malformations and Related Anomalies, Vol 1. RE Stevenson (ed). New York, Oxford University Press, 1993, pp 3–20

    Google Scholar 

  11. Moore KL: The Developing Human. Philadelphia, WB Saunders, 1988

    Google Scholar 

  12. Abacus Concepts: Statview SE + Graphics, 1988

  13. Skrabanek P: Smoking and statistical overkill. Lancet 340:1208–1209, 1992

    Google Scholar 

  14. Veereman-Wauters G, Monbaliu J, Meuldermans W, Woesterborghs R, Verlinden M, Heykants J, Rudolph CD: Study of the placental transfer of cisapride in the sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb. Drug Metab Disp 19:168–172, 1991

    Google Scholar 

  15. United States Pharmacopeial Convention Inc: Cisapride. In USP Dispensing Information Volume I: Drug Information for the Health Care Professional, 16th ed. Massachusetts, Rand McNally, 1996, pp 849–850

    Google Scholar 

  16. Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G: Safety of first trimester exposure to histamine H2 blockers: A prospective cohort study. Dig Dis Sci 41:1145–1149, 1996

    Google Scholar 

  17. Schardein JL: Chemically Induced Birth Defects. New York, Marcel Dekker, 1985, pp 452–466

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bailey, B., Addis, A., Lee, A. et al. Cisapride Use During Human Pregnancy (A Prospective, Controlled Multicenter Study). Dig Dis Sci 42, 1848–1852 (1997). https://doi.org/10.1023/A:1018898707449

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018898707449

Navigation